School of Pharmacy
BACKGROUND—1,3,4-Oxadiazole and imidazolidine rings are important heterocyclic compounds exhibiting a variety of biological activities. In this study, novel compounds with oxadiazole and imidazolidine rings were synthesized from 3-(methylsulfonyl)-2- oxoimidazolidine-1-carbonyl chloride and screened for insecticidal activities. The proposed structures of the 17 synthesized compounds were confirmed using elemental analysis, infrared (IR), proton nuclear magnetic resonance (1H-NMR), and mass spectroscopy. RESULTS—None of the compounds showed larvicidal activity at the tested concentrations against first-instar Aedes aegypti larvae. However, nine compounds exhibited promising adulticidal activity, with mortality rates of ≥80% at 5 μg per mosquito. Further dose–response bioassays were undertaken to determine median lethal dose (LD50) values. Compounds 1, 2b, 2c, 2d, 2 g, 3b, 3c, 3 g, and 3 h were effective, with typical LD50 values of about 5 – 10 μg per mosquito against female Ae. aegypti. Compounds 2c (bearing a nitro group on the aromatic ring; LD50 = 2.80 ± 0.54 μg per mosquito) and 3 h (double halogen groups at 2,4 position on the phenyl ring; LD50 = 2.80 ± 0.54 μg per mosquito) were the most promising compounds. CONCLUSION—Preliminary mode of action studies failed to show consistent evidence of either neurotoxic or mitochondria-directed effects. Further chemical synthesis within this series may lead to the development of new effective insecticides.
Digital Commons Citation
Tok, Fatih; Kocyigit-Kaymakcioglu, Bedia; Tabanca, Nurhayat; Estep, Alden S.; Gross, Aaron D.; Geldenhuys, Werner J.; Becnel, James J.; and Bloomquist, Jeffrey R., "Synthesis and structure-activity relationships of carbohydrazides and 1,3,4-oxadiazole derivatives bearing an imidazolidine moiety against the yellow fever and dengue vector, Aedes aegypti" (2018). Clinical and Translational Science Institute. 752.
Tok F, Kocyigit-Kaymakcioglu B, Tabanca N, et al. Synthesis and structure-activity relationships of carbohydrazides and 1,3,4-oxadiazole derivatives bearing an imidazolidine moiety against the yellow fever and dengue vector, Aedes aegypti. Pest Management Science. 2017;74(2):413-421. doi:10.1002/ps.4722